Drug intelligence / Profile preview

rabies vaccine (Vero cell) (Hualan Biological Vaccine Inc.)

Development stage
Unknown
Lead developer
Hualan Biological Bacterin
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

The Hualan rabies vaccine (Vero cell) is an inactivated, freeze-dried vaccine developed by Hualan Biological Bacterin Co. Ltd. for human rabies prophylaxis. Produced using a continuous Vero cell line in large-scale bioreactors, the vaccine features a specialized three-step purification process that ensures ultra-low DNA content and an antibiotic-free formulation, enhancing its safety profile. It is indicated for both pre-exposure and post-exposure immunization. In Phase 3 clinical trials, the vaccine was evaluated in both a traditional 5-dose intramuscular regimen (administered on days 0, 3, 7, 14, and 28) and an accelerated 4-dose (2-1-1) regimen (two doses on day 0, one on day 7, and one on day 21) against a marketed control vaccine. The Hualan vaccine has received a Drug Registration Certificate in China and is available for clinical use.

Other names
control vaccine-Hualan Biological Bacterin Co. Ltd.-rabiescontrol vaccineExperimental vaccineLyophilized Human Rabies Vaccine (Vero Cell)Hualan rabies vaccine

Beyond the preview

Go deeper on rabies vaccine (Vero cell) (Hualan Biological Vaccine Inc.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rabies vaccine (Vero cell) (Hualan Biological Vaccine Inc.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call